News
SILO
3.095
-13.06%
-0.465
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 12h ago
Silo Receives European Patent For Preventive PTSD Therapy SPC-15
NASDAQ · 2d ago
Silo Pharma granted European patent covering PTSD therapy
TipRanks · 2d ago
Silo Pharma Says EPO Grants Patent Covering Preventative Approach Of Lead Candidate SPC-15, Intranasal, Nose-To-Brain Treatment Targeting PTSD And Stress-Induced Affective Disorders
Benzinga · 2d ago
Weekly Report: what happened at SILO last week (0803-0807)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 5d ago
Silo Pharma’s QwikAgents Engages AWS Premier Tier Services Partner Caylent To Design And Build AWS-Native QwikAgents Platform
Benzinga · 6d ago
Weekly Report: what happened at SILO last week (0727-0731)?
Weekly Report · 08/03 09:38
Weekly Report: what happened at SILO last week (0720-0724)?
Weekly Report · 07/27 09:40
Silo Pharma files to sell 1.91M shares of common stock for holders
TipRanks · 07/24 20:10
Weekly Report: what happened at SILO last week (0713-0717)?
Weekly Report · 07/20 09:38
Silo Pharma Unit Eyes Faster AI Agent Development Through AMD Partnership
Benzinga · 07/14 15:45
Silo Pharma subsidiary QwikAgents joins AMD AI program
TipRanks · 07/14 13:20
Silo Pharma's Subsidiary Accepted Into Advanced Micro Devices' AMD AI Developer Program
Benzinga · 07/14 12:56
Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform
Barchart · 07/14 07:55
Weekly Report: what happened at SILO last week (0706-0710)?
Weekly Report · 07/13 09:39
Consumer Tech News (July 6-10): Micron Plans $250B US Expansion, Apple Signs $30B Broadcom Deal & More
Benzinga · 07/12 11:31
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 07/10 17:05
Silo Pharma prices $11.7M at-the-market offering at $6.45 per share
TipRanks · 07/10 12:16
Silo Pharma raises $4M in private placement; shares down
Seeking Alpha · 07/10 12:09
More
Webull provides a variety of real-time SILO stock news. You can receive the latest news about Silo Pharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About SILO
Silo Pharma, Inc. is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. The Company’s therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes programs, such as for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Its lead product candidate, SPC-15, is designed as a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for treatment of stress-induced psychiatric disorders such as PTSD and anxiety disorders. SPC-14 targets glutamate receptor NDMAR and serotonin 5-HT4 to address cognitive and neuropsychiatric symptoms in Alzheimer’s disease. SPU-16 is a candidate targeting central nervous system (CNS) disorders, with an initial indication for multiple sclerosis.